Feed
Briefings
Situations
Alpha
Sign in
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
rss · ft
2026-11-15T23:54:31Z
en
View original
AI brief
Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector
AI Brief
Your highlights
This article is available on the publisher's site.
Read on ft
Highlight